UpFront

Contributed by:

Taren Grom, Editor

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Awards… Abbott Named One of the Best Workplaces in Europe The Great Place to Work Institute named Abbott one of the Best ­Multinational Workplaces in Europe. The company was specifically ­honored for workplace leadership in Belgium, Denmark, Ireland, Norway, and Portugal. This is the third ­consecutive year that Abbott has earned this recognition. Bayer Executive Honored Bayer USA Foundation Executive ­Director Rebecca Lucore has been named as one of the 100 Women Leaders of STEM by STEMconnector. She is one of several women from across all industries in the United States who have demonstrated leadership and advocacy for STEM (science, technology, engineering and ­mathematics) education. Clinical Research Advantage Receives Awards Clinical Research Advantage, a ­community-based network of clinical trial sites, was honored with three ­silver and two bronze Stevie awards at the 10th Annual American ­Business Awards. The company received the silver award for Company of the Year in the pharmaceuticals category and a bronze award for the Fastest-Growing Company of the Year in the pharmaceuticals category. Cramer Wins Telly Awards Cramer, a creative marketing agency, has been recognized by the industry with six Telly Awards, two of which are silver, the Telly’s highest ­achievement. The Telly Awards honor the best in film and video. J&J Names Dr. Paul Janssen Award Winners Johnson & Johnson has named Dr. Victor Ambros and Dr. Gary ­Ruvkun the winners of the 2012 Dr. Paul Janssen Award for Biomedical Research. Dr. Ambros and Dr. Ruvkun won the award for their co-discovery of microRNAs (miRNAs) as central ­regulators of gene expression and ­development. These regulatory ­molecules have been implicated in a wide range of normal and ­pathological activities, including ­embryonic development, blood-cell specialization, muscle function, heart disease, and viral infections. Their ­discovery has opened new fields of ­research. Lilly Executive Receives Global Health Partner Award Project HOPE presented John Lechleiter, Ph.D., chairman, president, and CEO of Lilly with the ­inaugural Global Health Partner Award. The award ­recognizes Dr.­ ­Lechleiter’s leadership and the longstanding partnership ­between Lilly and Project HOPE, which continues to help change the lives of people in need through health ­programs, health education, and ­humanitarian assistance. Merck Serono Executive ­Honored Dr. Annalisa Jenkins, ­Executive VP, Head of Global Drug Development and Medical for Merck Serono, received the Red Door Award by Gilda’s Club New York City for her advocacy work on behalf of people living with cancer. Quintiles Named Top ­Workplace in the UK Quintiles has been named one of the top workplaces in the U­.K. by the Great Place to Work Institute. The biopharma ­services firm scored highly for its sense of pride and camaraderie, with its ­efforts in corporate social ­responsibility, well-being, and work-life balance. INDUSTRY at Large Since 2008, Cubist has awarded more than $1 million to STEM programs. Cubist Makes Commitment to STEM Programs Cubist Pharmaceuticals has awarded almost $300,000 in grants this year to benefit 16 ­organizations with ­science, technology, engineering, and mathematics (STEM) programs in Massachusetts. These grants ­reflect the company’s ongoing ­commitment to STEM education, with an emphasis on supporting programs for underserved ­middle- and high-school ­students in ­Massachusetts. As Cubist celebrates its 20th anniversary, it also marks the fifth year of its philanthropic program focused on ­supporting nonprofit organizations with STEM education initiatives. Milestones… Alnylam Pharmaceuticals Celebrates 10 Year Anniversary Transitioning from a small biotech startup to a pharmaceutical ­company, Alnylam’s ­persistence and determination have transformed an industry and continue to give millions of ­patients worldwide hope for the ­future. In only 10 years, there has been great success. Alnylam has shown proof of concept that RNAi can actually work in humans to treat ­disease. Alnylam’s CEO John Maraganore has been the leading the company since the beginning and has plans to further the company’s progress in the RNAi space moving forward. John Maraganore Global Drug Market to Expand The global market for medicines is poised to ­rebound from an expected low point between 3% and 4% growth in 2012 to between 5% and 7% in 2016, ­according to a new forecast by the IMS ­Institute for Healthcare Informatics. ­Annual global ­spending on medicines will rise from $956 ­billion in 2011 to almost $1.2 trillion in 2016. Millennium Laboratories Aims to Fight Prescription Drug Abuse Millennium Laboratories, a research-based ­clinical diagnostic company, has awarded a $250,000 grant to the WAKE UP! campaign in an effort to combat ­prescription drug misuse and abuse by teenagers. About one in five teens are currently ­suffering from prescription drug abuse. Specialty Medications A Concern Among Plan Sponsors More than 75% of plan sponsors say behavior-driven conditions are the greatest contributors to plan costs. A recent report, which polled ­benefit managers from 318 organizations ­representing more than 9 million covered lives, was conducted by Medco Health Solutions. In the survey, 36% of plan sponsors cited the rising utilization and cost of specialty ­medications as the greatest concern in ­managing their prescription plan. Another 38% cited overall drug costs. Quote of the Month… “Because CMS has yet to ­publish a final rule defining ­exactly what needs to be reported and when for the Sunshine Act, companies have had to prepare without ­having this essential ­information.” Liz Lewis Millennium: The Takeda Oncology Company BOOK Future15 Sponsored by: Klick?Health http://www.klick.com/future15 Podcasts Future of Pharmacovigilance: Five ­Imperatives That Will Drive Improved Business Outcomes Thought Leaders: Nagaraja Srivatsan, Venkat Venkataramanan, George Botsakos, Cognizant Reaching Healthcare Providers While ­Remaining Compliant Thought Leader: Erez Lapsker, MediScripts Global Biosimilar Development Thought Leader: Rodeina Challand, PRA Improve Adherence with Patient and Caregiver Support Programs Thought Leader: Lou Shapiro, Tunstall AMAC Life Sciences Whitepapers Practical Strategies for Engaging ­Healthcare Providers Sponsored by: MediScripts Unlocking the Value of Observational Research Sponsored by: Parexel Global Biosimilar Development Sponsored by: PRA Outsourcing in Regulatory Affairs: Insights from the Top Pharmaceuticals Sponsored by: Take?Solutions Increase Patient Adherence and Do More With Less Sponsored by: Tunstall AMAC Life Sciences Videos DIA Editor’s Take Videos http://www.pharmavoice.com/content/ industryevents/editorstake.html Impact 2012: Pinpointing Opportunities in Uncertain Times Sponsored by: Genpact

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK